Engineered mesenchymal stem cell exosomes loaded with miR-34c-5p selectively promote eradication of acute myeloid leukemia stem cells
Cancer Letters · 2023-10 · 575 · 216407
DOI: 10.1016/j.canlet.2023.216407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023-10. Verfasst von Jin Wen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Exosomes, MicroRNAs, Mesenchymal Stem Cells, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Most patients with acute myeloid leukemia (AML) relapse eventually because of the inability to effectively eliminate leukemia stem cells (LSCs), prompting the search of new therapies to eradicate LSCs. Our previous study demonstrated that miR-34c-5p promotes the clearance of LSCs in an AML mouse model, highlighting its potential as a therapeutic target for eradicating LSCs, but the effective delivery of miR-34c-5p to LSCs remains a great challenge. Here, we employed simultaneous two-step modifications to engineer mesenchymal stem cells (MSCs) and MSC-derived exosomes to create exosomes overexpressing the fused protein lysosome-associated membrane protein 2-interleukin 3 (Lamp2b-IL3) and hematopoietic cell E-selectin/L-selectin ligand (HCELL), and demonstrated that the engineered exosomes exhibited an enhanced ability for bone marrow homing and selective targeting of LSCs. Additionally, using a humanized AML mouse model, we confirmed that the engineered exosomes, loaded with miR-34c-5p, could selectively promote eradication of LSCs and impede the AML development in vivo. In summary, we successfully designed an effective delivery system and provided new insights into the development of novel therapies for delivering miRNA or other molecules to LSCs with greater cellular targeting specificity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Pediatrics, Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: liulingbo@hust.edu.cn.
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: 2018XH0216@hust.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wen, J., Chen, Y., Liao, C., Ma, X., Wang, M., Li, Q., Wang, D., Li, Y., Zhang, X., Li, L., Zhou, H., Zou, J., Liu, L., & Peng, D. (2023). Engineered mesenchymal stem cell exosomes loaded with miR-34c-5p selectively promote eradication of acute myeloid leukemia stem cells. Cancer Letters, 575, 216407. https://doi.org/10.1016/j.canlet.2023.216407
Vancouver
Wen J, Chen Y, Liao C, Ma X, Wang M, Li Q, et al. Engineered mesenchymal stem cell exosomes loaded with miR-34c-5p selectively promote eradication of acute myeloid leukemia stem cells. Cancer Letters. 2023;575:216407. doi:10.1016/j.canlet.2023.216407
BibTeX
@article{Wen2023,
author = {Wen, Jin and Chen, Ying and Liao, Chenxi and Ma, Xiao and Wang, Mengyuan and Li, Qian and Wang, Di and Li, Yingnan and Zhang, Xiaolan and Li, Lei and Zhou, Hao and Zou, Jing and Liu, Lingbo and Peng, Danyue},
title = {Engineered mesenchymal stem cell exosomes loaded with miR-34c-5p selectively promote eradication of acute myeloid leukemia stem cells},
journal = {Cancer Letters},
year = {2023},
volume = {575},
pages = {216407},
doi = {10.1016/j.canlet.2023.216407}
}
EUVIMED